Meag Munich Ergo’s Corteva CTVA Stock Holding History

Meag Munich Ergo’s Portfolio CTVA Stock Details CTVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-11,355	Closed	-$328K	–	276
2019 Q4	$328K	Sell	11,355 -39,646	-78%	-$1.05M	0.04%	338
2019 Q3	$1.41M	Buy	+51,001	New	+$1.47M	0.07%	291

Other funds holding CTVA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

IFP

Independent Franchise Partners London, United Kingdom $14.3B AUM 3.49% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meag Munich Ergo's CTVA Position: Q1 2020 in Review

Meag Munich Ergo sold out of Corteva (CTVA) in Q1 2020, closing a stake of 11,355 shares — an estimated $328K sold.

Meag Munich Ergo first reported a position in CTVA in Q3 2019 and held it in 2 quarters. The position peaked at $1.41M in Q3 2019. 902 funds tracked by Wall St. Rank hold CTVA as of Q1 2020.

Meag Munich Ergo reported no remaining Corteva position as of Q1 2020 after selling out during the quarter.
Meag Munich Ergo sold 11,355 Corteva shares in Q1 2020, an estimated $328K.
Meag Munich Ergo first reported a position in Corteva in Q3 2019 and held it in 2 quarters.
Meag Munich Ergo's Corteva position peaked at $1.41M in Q3 2019.
902 funds tracked by Wall St. Rank held Corteva as of Q1 2020.

Based on Meag Munich Ergo's 13F filing for Q1 2020, filed 23 Apr 2020.